Cargando…
Uptake and Diagnostic Yield of Chromosomal Microarray in an Australian Child Development Clinic
Autism is an etiologically heterogeneous developmental disorder for which the range of genetic investigations has expanded considerably over the past decade. Introduction of chromosomal microarray (CMA) to clinical practice has expanded the range of conditions which pediatricians are able to detect....
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939515/ https://www.ncbi.nlm.nih.gov/pubmed/27417464 http://dx.doi.org/10.3390/children1010021 |
_version_ | 1782442014779899904 |
---|---|
author | Mordaunt, Dylan Gabbett, Michael Waugh, Melanie O’Brien, Karen Heussler, Helen |
author_facet | Mordaunt, Dylan Gabbett, Michael Waugh, Melanie O’Brien, Karen Heussler, Helen |
author_sort | Mordaunt, Dylan |
collection | PubMed |
description | Autism is an etiologically heterogeneous developmental disorder for which the range of genetic investigations has expanded considerably over the past decade. Introduction of chromosomal microarray (CMA) to clinical practice has expanded the range of conditions which pediatricians are able to detect. This study reviewed the utilization, yield and cost of genetic investigations in a sample of children with pervasive developmental disorders (PDD) in an Australian metropolitan child development service. Six hundred and ninety eight patients with PDD were identified from the clinic population. One hundred and ten (15.7%) of the clinic population had undergone investigation with chromosomal microarray, 140 (20.0%) with karyotype (KT), and 167 (23.9%) with Fragile X testing (FRGX). Twelve (10.9%) CMA findings were reported, of which seven (6.3%) were felt to be the likely cause of the child’s clinical features. Five (3.5%) KT findings were reported, of which four (2.9%) were felt to be the likely cause of the child’s clinical features. Two patients (1.2%) were identified with Fragile X expansions. One fifth of the clinic’s recent PDD population had undergone testing with CMA. CMA appears to have increased the diagnostic yield of the genetic investigation of autism, in line with internationally reported levels. Number needed to test (NNT) and cost per incremental diagnosis, were also in line with internationally reported levels. |
format | Online Article Text |
id | pubmed-4939515 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-49395152016-07-12 Uptake and Diagnostic Yield of Chromosomal Microarray in an Australian Child Development Clinic Mordaunt, Dylan Gabbett, Michael Waugh, Melanie O’Brien, Karen Heussler, Helen Children (Basel) Article Autism is an etiologically heterogeneous developmental disorder for which the range of genetic investigations has expanded considerably over the past decade. Introduction of chromosomal microarray (CMA) to clinical practice has expanded the range of conditions which pediatricians are able to detect. This study reviewed the utilization, yield and cost of genetic investigations in a sample of children with pervasive developmental disorders (PDD) in an Australian metropolitan child development service. Six hundred and ninety eight patients with PDD were identified from the clinic population. One hundred and ten (15.7%) of the clinic population had undergone investigation with chromosomal microarray, 140 (20.0%) with karyotype (KT), and 167 (23.9%) with Fragile X testing (FRGX). Twelve (10.9%) CMA findings were reported, of which seven (6.3%) were felt to be the likely cause of the child’s clinical features. Five (3.5%) KT findings were reported, of which four (2.9%) were felt to be the likely cause of the child’s clinical features. Two patients (1.2%) were identified with Fragile X expansions. One fifth of the clinic’s recent PDD population had undergone testing with CMA. CMA appears to have increased the diagnostic yield of the genetic investigation of autism, in line with internationally reported levels. Number needed to test (NNT) and cost per incremental diagnosis, were also in line with internationally reported levels. MDPI 2014-05-09 /pmc/articles/PMC4939515/ /pubmed/27417464 http://dx.doi.org/10.3390/children1010021 Text en © 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Article Mordaunt, Dylan Gabbett, Michael Waugh, Melanie O’Brien, Karen Heussler, Helen Uptake and Diagnostic Yield of Chromosomal Microarray in an Australian Child Development Clinic |
title | Uptake and Diagnostic Yield of Chromosomal Microarray in an Australian Child Development Clinic |
title_full | Uptake and Diagnostic Yield of Chromosomal Microarray in an Australian Child Development Clinic |
title_fullStr | Uptake and Diagnostic Yield of Chromosomal Microarray in an Australian Child Development Clinic |
title_full_unstemmed | Uptake and Diagnostic Yield of Chromosomal Microarray in an Australian Child Development Clinic |
title_short | Uptake and Diagnostic Yield of Chromosomal Microarray in an Australian Child Development Clinic |
title_sort | uptake and diagnostic yield of chromosomal microarray in an australian child development clinic |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939515/ https://www.ncbi.nlm.nih.gov/pubmed/27417464 http://dx.doi.org/10.3390/children1010021 |
work_keys_str_mv | AT mordauntdylan uptakeanddiagnosticyieldofchromosomalmicroarrayinanaustralianchilddevelopmentclinic AT gabbettmichael uptakeanddiagnosticyieldofchromosomalmicroarrayinanaustralianchilddevelopmentclinic AT waughmelanie uptakeanddiagnosticyieldofchromosomalmicroarrayinanaustralianchilddevelopmentclinic AT obrienkaren uptakeanddiagnosticyieldofchromosomalmicroarrayinanaustralianchilddevelopmentclinic AT heusslerhelen uptakeanddiagnosticyieldofchromosomalmicroarrayinanaustralianchilddevelopmentclinic |